On 5 December the 2023 Zhejiang Venture Capital Summit and the Zhejiang venture capital and innovation matchmaking event, hosted by the Zhejiang Department of Science and Technology and organised by the Zhejiang Venture Capital Association with the Hangzhou branch of China Everbright Bank, concluded in Hangzhou.
The 2023 Zhejiang venture capital annual lists were released at the event. Westlake Pharmaceuticals was named to the “2023 Zhejiang Top 50 most investable innovative companies”.
The event was themed “focusing on high-quality development, boosting new momentum for venture capital”. Among the speakers and guests were Guanglie Mao, former deputy party secretary and deputy director of the Zhejiang People’s Congress Standing Committee and honorary president of the association; Feizhang Qiu, former deputy party secretary and deputy director of the department and president of the association; Tufa Zhou, party member and deputy director of the department; Wenjun Fu, director of the finance division at the provincial development and reform commission; Shi Feng, director of the finance division at the Hangzhou development and reform commission; and Jun Zheng, chairman of Zhejiang Financial Holdings Investment Management. More than 350 people from venture firms and technology companies attended.
The list was compiled by Rongzhong across two categories — the top 50 most investable innovative companies and the top 50 venture capital institutions — using 2022 and 2023 data submitted by participating institutions together with expert review, following open and fair procedures.
At the matchmaking event that afternoon Westlake Pharmaceuticals presented as a representative innovative company. Dr. Dongdong Liang, Chief Operating Officer, presented “Discovery and industrialisation of original small-molecule drugs”, which drew strong interest and recognition from the reviewers.
Inclusion recognises the company’s progress in recent years and will spur it on. Westlake Pharmaceuticals will stay focused on original drug discovery and on creating social value.